• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤抑制基因p53杂合性缺失的半自动定量检测

Semiautomated quantitative detection of loss of heterozygosity in the tumor suppressor gene p53.

作者信息

Hahn M, Matzen S E, Serth J, Pingoud A

机构信息

Justus-Liebig-Universität, Giessen, Germany.

出版信息

Biotechniques. 1995 Jun;18(6):1040-7.

PMID:7546705
Abstract

The most frequently altered gene in diverse tumor types is the tumor suppressor gene p53. Typically, normal function is inactivated by point mutation of one allele and deletion of the other. Therefore, loss of heterozygosity (LOH) of intragenic polymorphic markers is a strong indication for p53 involvement in a cancerous lesion. This study shows that a highly polymorphic short tandem repeat (STR) within intron 1 of p53 is an excellent marker for quantitative evaluation of LOH in tumor samples, whose multicolor, fluorescently tagged PCR products are analyzed and quantitated on an automated DNA sequencer. The range of error was analyzed in detail. Discrete allelic profiles were obtained following amplification of DNA from microdissected cell samples of patients with urogenital tumors. By calculating qLOH, the relative allele ratio of a tumor compared with healthy tissue, a quantitative expression for the LOH is obtained. PCR-based tumor DNA typing using fluorescent STR primers and automated analysis provides an enhanced level of accuracy and sensitivity required for routine analysis in clinical practice, where large numbers of tumor samples have to be processed.

摘要

在多种肿瘤类型中,最常发生改变的基因是肿瘤抑制基因p53。通常,一个等位基因的点突变和另一个等位基因的缺失会使正常功能失活。因此,基因内多态性标记的杂合性缺失(LOH)是p53参与癌性病变的有力指征。本研究表明,p53基因内含子1内的一个高度多态性短串联重复序列(STR)是肿瘤样本中LOH定量评估的优良标记,其多色、荧光标记的PCR产物在自动DNA测序仪上进行分析和定量。详细分析了误差范围。对泌尿生殖系统肿瘤患者显微切割细胞样本的DNA进行扩增后,获得了离散的等位基因图谱。通过计算qLOH(肿瘤与健康组织的相对等位基因比率),可得到LOH的定量表达。使用荧光STR引物和自动分析的基于PCR的肿瘤DNA分型,为临床实践中的常规分析提供了更高水平的准确性和灵敏度,因为临床实践中需要处理大量肿瘤样本。

相似文献

1
Semiautomated quantitative detection of loss of heterozygosity in the tumor suppressor gene p53.肿瘤抑制基因p53杂合性缺失的半自动定量检测
Biotechniques. 1995 Jun;18(6):1040-7.
2
Polymerase chain reaction-based approaches for detection of allelic loss in the p53 tumor suppressor gene in colon neoplasms.基于聚合酶链反应的方法检测结肠肿瘤中p53肿瘤抑制基因的等位基因缺失。
Am J Gastroenterol. 1997 Feb;92(2):307-12.
3
DNA typing with fluorescently tagged short tandem repeats: a sensitive and accurate approach to human identification.使用荧光标记短串联重复序列进行DNA分型:一种灵敏且准确的人类身份识别方法。
Biotechniques. 1993 Jul;15(1):100-19.
4
Detection of loss of heterozygosity in the p53 tumor suppressor gene using a PCR-based assay.
Pathol Res Pract. 1995 Jun;191(5):399-402. doi: 10.1016/S0344-0338(11)80725-9.
5
Semiautomated assessment of loss of heterozygosity and replication error in tumors.肿瘤中杂合性缺失和复制错误的半自动评估
Cancer Res. 1996 Jul 15;56(14):3331-7.
6
Detection of loss of heterozygosity in the p53 tumor-suppressor gene with PCR in the urine of patients with bladder cancer.采用聚合酶链反应(PCR)检测膀胱癌患者尿液中p53肿瘤抑制基因杂合性缺失
J Urol. 2000 Mar;163(3):1039-42.
7
Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.在17p13.3上,位于TP53远端的一个基因作为无p53突变的乳腺肿瘤中等位基因缺失靶点的证据。
Cancer Res. 1994 Aug 1;54(15):4200-6.
8
Detection of 17p loss in gastric carcinoma using polymerase chain reaction.
Lab Invest. 1995 Feb;72(2):232-6.
9
Sensitive detection of loss of heterozygosity in the TP53 gene in pancreatic adenocarcinoma by fluorescence-based single-strand conformation polymorphism analysis using blunt-end DNA fragments.使用平端DNA片段通过基于荧光的单链构象多态性分析灵敏检测胰腺腺癌中TP53基因杂合性缺失
Genes Chromosomes Cancer. 1996 Mar;15(3):157-64. doi: 10.1002/(SICI)1098-2264(199603)15:3<157::AID-GCC2>3.0.CO;2-1.
10
Producing STR locus patterns from bloodstains and other forensic samples using an infrared fluorescent automated DNA sequencer.使用红外荧光自动DNA测序仪从血迹和其他法医样本中生成STR基因座模式。
J Forensic Sci. 1996 May;41(3):418-24.

引用本文的文献

1
Applying microsatellite multiplex PCR analysis (MMPA) for determining allele copy-number status and percentage of normal cells within tumors.应用微卫星多重 PCR 分析 (MMPA) 确定肿瘤内等位基因拷贝数状态和正常细胞的百分比。
PLoS One. 2012;7(8):e42682. doi: 10.1371/journal.pone.0042682. Epub 2012 Aug 15.
2
Dissecting loss of heterozygosity (LOH) in neurofibromatosis type 1-associated neurofibromas: Importance of copy neutral LOH.解析 1 型神经纤维瘤病相关神经纤维瘤中的杂合性丢失(LOH):拷贝数中性 LOH 的重要性。
Hum Mutat. 2011 Jan;32(1):78-90. doi: 10.1002/humu.21387.
3
Single nucleotide polymorphism array analysis of flow-sorted epithelial cells from frozen versus fixed tissues for whole genome analysis of allelic loss in breast cancer.
用于乳腺癌等位基因缺失全基因组分析的冷冻组织与固定组织中流式分选上皮细胞的单核苷酸多态性阵列分析。
Am J Pathol. 2002 Jan;160(1):73-9. doi: 10.1016/S0002-9440(10)64351-9.
4
Loss of heterozygosity analysis using whole genome amplification, cell sorting, and fluorescence-based PCR.使用全基因组扩增、细胞分选和基于荧光的聚合酶链反应进行杂合性缺失分析。
Genome Res. 1999 May;9(5):482-91.